Anti-Allergic & Anti-Inflammatory

Tafazol (Eye Drops)
(Zinc phenolsulphonate/Sulfacetamide sodium/Naphazoline HCl/Lidocaine HCl)

Each ml of contains:
sulfacetamide sodium 30 mg
zinc phenolsulphonate 5 mg
naphazoline hydrochloride 0.05 mg
lidocaine hydrochloride 7.5 mg

- Exacerbations of seasonal and perennial allergic conjunctivitis;
- Treatment of non-complicated conjunctivitises.

- Known hypersensitivity to any of drug components;
- Children aged under 6 years.

The preparation is well tolerated in the recommended doses. In rare cases local allergic reactions, burning sensation or irritation may occur.

1 drop is instilled in conjunctival sac of a sore eye 1-3 times per day depending on the severity of the disease. The course treatment makes 7 days; if necessary the dose adjustment is possible under doctor's prescription.

Tafazol is not compatible with the preparations containing the salts of silver.

It is not recommended to wear contact lenses. One should remove hard contact lenses before eye drops instillation. To wear them again is possible not less than 15-20 min after the preparation application. Special caution must be applied in patients with heart failure, arterial hypotension, sinus bradicardia. One should avoid to contact of dropper with any surfaces. It helps to prevent microbial contamination of vial content.

Drug application is possible only under physician's prescription if expected curative effect for mother exceeds the possible risk for fetus. At the application of the preparation during lactation the breast feeding should be ceased.

10 ml plastic vial with a dropper and screwing protective cap, equipped with protective ring. 1 vial in a carton box together with enclosed insert.

Anti-Allergic &

Clodifen (Eye Drops)

Eyecrol (Eye Drops)

Medexol (Eye/Ear Drops)

Medrolgin (Eye Drops)

Neladex (Eye Ointment)

Neladex (Eye/Ear Drops)

Pallada (Eye Drops)

Tafazol (Eye Drops)

 Events & Exhibitions


A patient with the fundus lesion shown is at risk for developing:

a. cystoid macular edema
b. choroidal neovascularization
c. retinal detachment
d. hypotony maculopathy

WOC 2014 in Tokyo, Japan
Online submission of abstracts will open on March 1, 2013. The deadline for abstract submission is July 26, 2013 at midnight in Tokyo. Submissions will be reviewed by the WOC 2014 Scientific Program Committee. Primary authors will be notified of acceptance by early October, 2013.

Researchers Develop Gene Therapy That Could Correct A Common Form Of Blindness
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults.

Oxygen Therapy Helps Heal Chemical and Thermal Burns in the Eyes
Scientists at the Department of Ophthalmology, Ahvaz Jundishapur University of Medical Sciences, treated 24 eyes of 22 patients with acute chemical and thermal burns in their eyes.

Glaucoma Causes Higher Risk of Falls Among Older Adults
Glaucoma can affect a person's downward field of view, and this seems to be causing a higher risk of falls resulting in injury among older people with the eye disease.

Why Do Birds Fly into Power Lines? Is Poor Vision the Problem?
esearch suggests that collision with human structures is the largest unintended human cause of bird deaths

Diabetes and Hypertension Increase Glaucoma Risk
People with diabetes and/or hypertension are more likely to develop open-angle glaucoma (OAG) as well.

Be Careful Out There: Fireworks Caused 1,300 Eye Injuries in One Month in 2010
Sparklers caused about 200 U.S. eye injuries during a one-month period in 2010.

High Visual Perception Ability in Autistic People Explained
It has been noticed before that autistic people are highly able to process visual information, and this may be why.

Why Cold Temperatures Increase Eye Dryness
In fact, the meibum can solidify in cold temperatures and block the meibomian gland ducts

Home      |      Site Map      |      Terms of Use      |      Privacy Policy

2012 World Medicine Ophthalmics. All Rights Reserved.